The percentage of involved patients illustrated a decreasing trend as the OLGA stage increased (58.3%, 27.1%, 8.3%, and 6.3% in stages I, II, III, and IV, respectively).
← all excerpts
Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran.
1
—
—